2026-10-25
BrightView Holdings, clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 27,087 +1.72%
S&P 7,401 +0.65%
GOLD $4,073 −1.00%
BTC $75,828 −0.15%
VIX 24.55 −12.88%
latest tape · as of 20:03 UTC
The Screen · Industrials · Specialty Business Services
BrightView Holdings, Inc.
BV · the NYSE · USD · Market cap $995M · 18,200 employees
BrightView Holdings, Inc., through its subsidiaries, provides commercial landscaping services in the United States.
Not yet scored11.78 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price11.78 USD at the 5 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 5 Nov 2026
- Our regime readAccumulation, as of 5 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.00)
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $9.00 to $11.79, base estimate $10.25 (screen dated 2026-11-05).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.00, read 2026-10-29
- Ethical screen not yet scored
Price11.78 USD
Fair value10.25
Ethical score70.0/100
Value readOvervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-25Read Accumulation10.75+9.6% to today ✓Markdown gives way to Accumulation
2026-10-11Read Markdown10.49+12.3% to today Distribution gives way to Markdown after a 9% slide in 7 weeks
2026-08-24Read Distribution11.58+1.7% to today Markup gives way to Distribution after a 10% slide in 8 weeks
2026-07-02Read Markup12.89-8.6% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its accumulation label.
BrightView Holdings, Inc. holds its Accumulation at $11.78. Consolidating, no directional conviction, held for 40 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 40 days |
| Price at the screen | $11.78 |
| Valuation | N/A trailing · 17.60 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.20 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 26.92% | Below 33% | Interest-bearing debt is just 26.9% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 13.79% | Below 49% | Money owed to the company is 13.8% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
BrightView Holdings, clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
BrightView Holdings, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 27%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 5 Nov 2026: it trades above our $10.25 fair value estimate, 1.30% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. The price runs 14.9% above the base estimate.
Third-party analyst targets: 10 covering, consensus Buy. The average target sits +27% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $10.25, with a range of $9.00 to $11.79, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCommercial Lawns That Offer Little Growth
Picture the team that keeps corporate campuses and shopping centres looking neat every month. BrightView handles that recurring work across the United States, yet revenue is expanding only 6 percent a year while profit margins sit at 2 percent and return on equity at 3 percent. At a forward multiple of 20 times those thin returns, the shares sit just 7 percent below our fair value and earn no opportunity rating despite clearing the ethical screen.
The analyst crowd still calls it a buy with a 16 dollar median target, but the numbers show a business that is neither scaling fast nor earning attractive returns on capital. An unknown moat leaves it exposed to local competitors who can undercut on price without much effort.
Weather events, commercial-property spending cuts and wage pressure can all hit margins quickly. The modest valuation gap does not compensate for the limited growth or thin profitability on offer. Analysis, not advice.
| Forward P/E | 17.6xexpensive even after accounting for its growth |
| EPS, trailing | -0.24 |
| EPS, forward | 0.61 |
| Revenue growth | +1.3%slow but positive growth |
| Profit margin | 0.7%barely profitable |
| Return on equity | 1.2%a modest return on shareholder capital |
| FCF yield | -2.34% |
| Debt to equity | 0.55moderate, manageable leverage |
| Current ratio | 1.28adequate liquidity, worth monitoring |
| Beta | 1.20moves a little more than the market |
| Short interest, float | 0.34% |
| 52-week range | 9.82 - 15.00 |
| Market cap | $995M |
| Employees | 18,200 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBV trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-06
Accumulation $11.78
-1.7% Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it none, with a mean price target of $17. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-05
Accumulation $11.98
+1.7% Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it none, with a mean price target of $17. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04
Accumulation $11.78
+0.1% Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it none, with a mean price target of $17. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03
Accumulation $11.77
+0.0% Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it none, with a mean price target of $17. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01
Accumulation $11.77
+9.5% Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 9.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it none, with a mean price target of $17.
2026-10-25
Accumulation · changed $10.75
+2.1% Entry 9
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it none, with a mean price target of $17.
2026-10-18
Markdown $10.53
+0.4% Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it none, with a mean price target of $17.
2026-10-11
Markdown · changed $10.49
-1.4% Entry 7
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it none, with a mean price target of $17.
2026-10-02
Distribution $10.64
-8.1% Entry 6
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 8.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it none, with a mean price target of $17.
2026-08-24
Distribution · changed $11.58
-20.2% Entry 5
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 20.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it none, with a mean price target of $17.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- BrightView Goes Pink for Third Annual Breast Cancer Awareness Campaign Yahoo Finance · 1 Oct 2026
- Spotting Winners: BrightView (NYSE:BV) And Environmental and Facilities Services Stocks In Q2 Yahoo Finance · 25 Sep 2026
- BrightView (BV): Buy, Sell, or Hold Post Q2 Earnings? Yahoo Finance · 22 Sep 2026
- BrightView Holdings (BV) Preferred Dividend Keeps Valuation Questions In Play Yahoo Finance · 21 Sep 2026
- 1 Industrials Stock with Exciting Potential and 2 We Brush Off StockStory · 18 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
KODKEastman Kodak Company
RHLDResolute Holdings Management, Inc.
LZLegalZoom.com, Inc.
BKSYBlackSky Technology Inc.
CASSCass Information Systems Inc
THTarget Hospitality Corp.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-14 | Pete Sessions | Republican | sell | 15K–50K |
| 2026-09-14 | Pete Sessions | Republican | sell | 15K–50K |
| 2026-09-14 | Pete Sessions | Republican | sell | 15K–50K |
| 2026-09-04 | Ro Khanna | Democrat | sell | 15K–50K |
| 2026-09-04 | Ro Khanna | Democrat | sell | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $13.04 | -1.8% | · | $982 | -1.8% |
| 2 months | $11.78 | +8.7% | · | $1,087 | +8.7% |
| 3 months | $11.65 | +10.0% | · | $1,100 | +10.0% |
| 6 months | $12.96 | -1.2% | · | $988 | -1.2% |
| 1 year | $16.33 | -21.6% | · | $784 | -21.6% |
| 2 years | $13.91 | -7.9% | · | $921 | -7.9% |
| 3 years | $7.28 | +76.0% | · | $1,760 | +76.0% |
| 5 years | $17.46 | -26.6% | · | $734 | -26.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BV does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.